NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ARLAN BIOTECH

ARLAN BIOTECH

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://arlanbiotech.com/

Last Round

Seed

Jul 1, 2026

Est. Valuation

$12.5M

Total Funding Raised

$642,400

Momentum

Top 5%

of companies Caplight tracks

Company Overview

ARLAN BIOTECH is a biotechnology company that has developed a generative AI-powered SaaS platform to accelerate the discovery and development of single-domain antibodies.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Revenue Share, Services & Consulting

AI Layer

Application

Keywords

antibody discoverygenerative AInanobody designAI drug discoveryprotein binderde novo designin silico drug discoveryphysics-aware AIdiagnostic test kitssynthetic nanobodiesAI-as-a-servicedrug development platformbiotech SaaSVHHdigital biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ARLAN BIOTECH Comparables

Compare ARLAN BIOTECH with similar companies based on industry and business-model similarity.

ARLAN BIOTECH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EVQLV
85%
Antiverse
83%
Chai Discovery
80%

ARLAN BIOTECH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 1, 2026
GrantMay 26, 2025
Pre SeedFeb 28, 2025

Key People

Founding team and executive leadership

Dauken Seitkali

CTO and Co-Founder

Founding Team

ARLAN BIOTECH Investors

Notable investors and investment history

ARLAN BIOTECH investors
InvestorRounds
StartXSeed
Mercury SoftwarePre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    $610K round led by Mercury Software

ARLAN BIOTECH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ARLAN BIOTECH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ARLAN BIOTECH's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range4
Year Founded2021
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.